Neurotechnology startup Mave Health has secured $2.1 million (around Rs 18 crore) in a seed funding round led by Blume Ventures.
The round also saw participation from Inuka Capital, Stanford Angels, founders of Groww, Raymond Russell, Aureolis Ventures, Juhi Bhatnagar, and existing investor All In Capital.
This follows its earlier $750K pre-seed round raised in November 2023.
The company plans to use the fresh capital to launch its wearable headset in the United States and India and to scale its manufacturing capabilities.
Founded in 2023 by Dhawal Jain, Jai Sharma, and Aman Kumar, Mave Health builds non-invasive wearable devices designed to support focus, mood, and stress regulation. The company operates from Bengaluru and San Francisco.
Its flagship headset uses transcranial direct current stimulation (tDCS) to deliver low-intensity electrical currents to the prefrontal cortex through short daily sessions. The device is lightweight and designed for use during regular daily activities, with battery life lasting up to a month on typical usage.
Mave’s companion application allows users to log sessions, personalise usage protocols, and track progress. The company states that it does not collect brain data through the platform. The device is currently available for pre-order in India and the US, with shipments expected to begin in April 2026.
The startup reports early traction with more than 500 beta users and three limited product batches selling out within 36 hours. Based on user-reported data, a majority of users have seen improvements in productivity, stress levels, and overall mood within a few weeks of usage.
